Zelanna Goldberg
Overview
Zelanna Goldberg received $2M in total compensation, including $181K in salary, at Nivalis Therapeutics in 2021.
Source: SEC filing on April 29, 2022.
Related executives
We found seven more executives who work or worked at Nivalis Therapeutics.
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
Stanford Peng
Nivalis Therapeutics
President and Head of Research and Development
Paul Rickey
Nivalis Therapeutics
Chief Financial Officer
Mark Litton
Nivalis Therapeutics
Chief Operating Officer
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
Jon Congleton
Nivalis Therapeutics